NEW YORK (GenomeWeb News) – SuperArray Bioscience has licensed gene-silencing intellectual property from the Carnegie Institution, the firm said today.
SuperArray will use Carnegie’s technology to offer RNAi-based gene silencing products for studies including gene-specific siRNA and DNA-based RNAi expressing short hairpin RNA. It also has the right to pass on the technology to end users performing DNA-based RNA interference, said SuperArray.
The Frederick, Md.-based company said the agreement will allow it to generate gene-specific RNAi for every gene in the human, rat, and mouse genomes.
Financial terms of the agreement were not released.